Among 140 patients who underwent colonoscopy or a colonoscopy-plus-EGD, "inadequate bowel preparation" (stool retained in the bowel) was observed in 21.3% of those who were taking a GLP-1 medicine ...

"If my body deserves comfort then my brain deserves comfort too." The post Lizzo Admits Feeling “Really Bad” For Overeating ...

If you’ve been trying to reach a healthier weight, you may be considering semaglutide medications like Ozempic and Wegovy.

Ozempic-curious people are taking a novel approach to using the blockbuster weight loss drug — and some doctors are even ...

With the third quarter of 2024 ending, the discourse on the stock market for global equities has shifted back to interest ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard Jørgensen over the high price of the company’s diabetes and obesity drugs, Ozempic ...

U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established drugmakers and an emerging market of compounded versions as telehealth ...

AbbVie Humira, Pfizer/BioNTech COVID-19 shot may not make top 10 pharma drugs in 2024, with Novo Nordisk Ozempic and ...

Weight-loss drugs like Ozempic and Wegovy have become household names in recent years. But here's why they may not work for ...

Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.